Scribe Therapeutics Inc.

NASDAQ:SCTX

Biotechnology

Healthcare
$15.77 -4.80%

-$0.91 today

Market cap
$255.19M
Beta
0.00

Volume 0.27M

Average 0.98M

Price history

Scribe Therapeutics Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+5.13%

Period high

$37.25

Period low

$15.00

Latest

$15.77

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 12, 2026Nov 12, 2026
10-QNov 12, 2026Nov 12, 2026
10-QSep 2, 2026Sep 2, 2026
8-KSep 2, 2026Sep 2, 2026
SC 13GAug 3, 2026Aug 3, 2026
SC 13DJul 30, 2026Jul 30, 2026
SC 13DJul 30, 2026Jul 30, 2026
4Jul 29, 2026Jul 29, 2026
4Jul 29, 2026Jul 29, 2026
SC 13DJul 29, 2026Jul 29, 2026
4Jul 29, 2026Jul 29, 2026
4Jul 29, 2026Jul 29, 2026
4Jul 28, 2026Jul 28, 2026
4Jul 28, 2026Jul 28, 2026
4Jul 27, 2026Jul 27, 2026

Competitors

Who does Scribe Therapeutics Inc. compete with?

Open similar companies to compare their filings and price history.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Questions

Filing questions

Common questions about SCTX's filings, answered from its disclosures.

What is the latest SCTX filing?

The latest filing shown is 8-K dated Nov 12, 2026.

How many recent filings does SCTX have?

Intrinsic Alpha currently shows 20 recent filings for SCTX.